TMED logo

EGF Theramed Health Corp. Stock Price

CNSX:TMED Community·CA$1.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

TMED Share Price Performance

CA$0.09
0.05 (125.00%)
CA$0.09
0.05 (125.00%)
Price CA$0.09

TMED Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk and slightly overvalued.

5 Risks
1 Reward

EGF Theramed Health Corp. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$3.2m

Other Expenses

-CA$3.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.28
0%
0%
-16.8%
View Full Analysis

About TMED

Founded
n/a
Employees
n/a
CEO
Connor Yuen
WebsiteView website
www.egftheramedhealth.com

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.

Recent TMED News & Updates

Recent updates

No updates